goldy vs cancer

Patient Care

Ed Greeno with patient

M Health logo


The Masonic Cancer Center's clinical partner is University of Minnesota Health. Visit mhealth.org/cancer to find information about cancer care, providers, and cancer clinic locations.

Cancer Information Nurse Line

Reach a nurse specializing in cancer care, Monday through Friday from 8 a.m. to 4:30 p.m.
Phone: 612-624-2620
Email: ccinfo@umn.edu

Clinical Trials

Glove and vial

New cancer treatments must prove to be safe and effective in scientific studies with a certain number of patients before they can be made widely available. Through clinical trials, researchers learn which approaches are more effective than others.

Our Research Focus

Jeffrey Miller, M.D.

The Masonic Cancer Center brings together scientists from different disciplines to discover processes that affect cancer. It is home to state-of-the-art research tools and some of the world's top cancer researchers in:

Featured News

Ingbar and Wagner

University of Minnesota opens clinical trial for new treatment of COVID-19

MINNEAPOLIS, MN- August 13, 2020 - A patient with COVID-19 and lung failure at the University of Minnesota is the first to be treated in the U.S. on a new FDA-approved clinical trial determining the safety and effectiveness of mesenchymal stem cells (MSCs).

Drs. Rhein and Miller

University of Minnesota expands clinical investigation of engineered iPSC-derived NK cells, opening U.S. clinical trial for the treatment of COVID-19

MINNEAPOLIS, MN- August 6, 2020 - The first patient has received treatment in a new clinical trial that has opened at the University of Minnesota to test whether a novel cell therapy currently under clinical investigation as a treatment for acute myeloid leukemia (AML) and lymphoma can be effective as a treatment for COVID-19. The first-of-its-kind, engineered iPSC-derived natural killer (NK) cell product candidate, FT516, may play a role in diminishing viral replication of the novel coronavirus.